Published in:
01-10-2019 | Dyslipidemia | International Corner
Comorbid conditions in individuals assessed by SPECT: Study of a reference cardiology center in Mexico City
Authors:
Neftali Eduardo Antonio-Villa, MD/PhD (PECEM) Program, Nilda Espínola-Zavaleta, MD, PhD, Isabel Carvajal-Juárez, MD, Alondra Noe Flores-Garcia, MD, Erick Alexanderson-Rosas, MD
Published in:
Journal of Nuclear Cardiology
|
Issue 5/2019
Login to get access
Abstract
Background
There is an increasing prevalence of comorbidities in patients with ischemic heart disease (IHD) in developing countries. The aim of this work is to assess the prevalence of comorbidities and associated factors for IHD among patients at a reference cardiology center.
Design and Methods
This was a cross-sectional study. A complete clinical history which focused on the main comorbidities, previous myocardial infarction, and the main reason of referral was assessed. A single-photon emission computed tomography (SPECT) myocardial perfusion study (MPS) with two protocols was performed.
Results
We included 1998 patients, 64.2% male, median age 63 (I.R.: 56–71) years. 1514 (75.8%) subjects had at least one associated comorbidity. The main comorbidity was diabetes (T2D) (772: 38.6%), followed by systemic hypertension (737: 36.9%), smoking (518: 25.9%), and dyslipidemia (517: 25.9%). 806 (40.3%) had histories of previous myocardial infarctions. The main cause of referral was angina (923: 46.2%). We identified 1330 (66.5%) abnormal MPS. 460 (23%) had ischemia, 292 (14.6%) infarction, and 578 (28.9%) ischemia and infarction.
Conclusion
An increased prevalence of comorbidities was found in patients who were studied in the Nuclear Cardiology Department (NCD): most of them had traditional risk factors attributable to myocardial infarction. A great percentage were newly diagnosed with both ischemia and infarction.